Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The objective of the study is to compare the pharmacokinetics profiles and safety of Evogliptin in patients wit hepatic dysfunction versus healthy volunteers after single oral dose of Evogliptin
Epistemonikos ID: f146ff2fb9f74ac9895aede69da32acb050c3c57
First added on: May 13, 2024